Inflammation and cancer: Back to Virchow?

Lancet

Volumn 357, Issue 9255, 2001, Pages 539-545

  Balkwill, Fran ^a   Mantovani, Alberto ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTINEOPLASTIC AGENT; BETA CHEMOKINE; CELECOXIB; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYCLOOXYGENASE 2; CYTOKINE; DNA; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P53; THALIDOMIDE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANGIOGENESIS; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHRONIC INFLAMMATION; CLINICAL TRIAL; COLON CANCER; COLON POLYPOSIS; DNA DAMAGE; DNA POLYMORPHISM; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY CELL; MALIGNANT NEOPLASTIC DISEASE; MYELOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; WOUND HEALING;

EID: 0035901090     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04046-0     Document Type: Review

References (65)

1. The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment
2. Ulcerative colitis and colorectal cancer
3. Quantitative assessment of the leucocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines
4. The origin and function of tumor-associated macrophages
5. Cytokine regulation of endothelial cell function
6. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
7. The chemokine receptor switch paradigm and dendritric cell migration: Its significance in tumor tissues
8. High expression of the CC chemokine TARC in Reed-Sternberg cells: A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma
9. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
10. Tumors: Wounds that do not heal
11. Involvement of platelets in tumour angiogenesis?
12. A cytokine profile of normal and malignant ovary
13. Candidate genes for hypoxic tumor phenotype
14. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
15. Clinical applications of TNF-a in cancer
16. Tumor necrosis factor and its receptors in human ovarian cancer
17. Association of turmour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
18. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
19. Paradoxical, effects of tumour necrosids factor in experimental ovarian cancer
20. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice
21. Cytokines in non-genotoxic hepatocarcinogenesis
22. Tumour necrosis factor-a deficient mice are resistant to skin carcinogenesis
23. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline
24. IL-18 regulates IL-1b-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
25. New insights into role of microenvironment in multiple myeloma
26. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer
27. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma
28. Reed-Sternberg cell genome expression supports a B-cell lineage
29. The tumorigenic and angiogenic effects of MGSSA/GRO proteins in melanoma
30. Chronic growth stimulation of human adult melanocytes by inflammatory mediators in vitro: Implications for nevus formation and initial steps in melanocyte oncogenesis
31. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma
32. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma
33. Chemokine receptors CXCR-1/2 activate mitogen activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells
34. Purification and identification of chemokines potenetially involved in kidney-specific metastasis by a murine lymphoma variant: Induction of migration and NFkB activation
35. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation
36. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
37. A proinflammatory cytokine inhibits p53 tumor suppressor activity
38. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
39. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
40. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
41. Chemotactic factors, passive invasion and metastasis of cancer cells
42. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelia cells correlates with VLA-4 expression
43. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype
44. Other function, other genes: Alternative activation of antigen-presenting cells
45. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation of tumor-associated macrophages
46. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
47. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant
48. The Kaposi's sarcoma-related herpes virus (KSHV)-encoded chemokine vMIP-1 is a specific agonist for the CC receptor (CCR)8
49. Role of alpha 1 acidic glycoprotein in the in vivo resistance of human BCR-ABL (+) leukemic cells to the abl inhibitor STI571
50. Immunosuppressive activity in the retroviral envelope protein P15E and its possible relationship to neoplasia
51. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens
52. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
53. Frequent genotype changes at -308 and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer
54. A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer
55. Anti-cytokine therapy for rheumatoid arthritis
56. Biology of cachexia
57. Antitumor activity of thalidomide in refractory multiple myeloma
58. Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells
59. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
60. Aspirin use and risk of fatal cancer
61. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database
62. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
63. The effect of celecoxib a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis